Literature DB >> 19653691

Practical catalytic asymmetric synthesis of diaryl-, aryl heteroaryl-, and diheteroarylmethanols.

Luca Salvi1, Jeung Gon Kim, Patrick J Walsh.   

Abstract

Enantioenriched diaryl-, aryl heteroaryl-, and diheteroarylmethanols exhibit important biological and medicinal properties. One-pot catalytic asymmetric syntheses of these compounds beginning from readily available aryl bromides are introduced. Thus, lithium-bromide exchange with commercially available aryl bromides and n-BuLi was followed by salt metathesis with ZnCl(2) to generate ArZnCl. A second equivalent of n-BuLi was added to form the mixed organozinc, ArZnBu. In the presence of enantioenriched amino alcohol-based catalysts, ArZnBu adds to aldehydes to afford essentially racemic diarylmethanols. The low enantioselectivities were attributed to a LiCl-promoted background reaction. To inhibit this background reaction, the chelating diamine TEEDA (tetraethylethylene diamine) was introduced prior to aldehyde addition. Under these conditions, enantioenriched diarylmethanols were obtained with >90% ee. Arylations of enals generated allylic alcohols with 81-90% ee. This procedure was unsuccessful, however, when applied to heteroaryl bromides, which was attributed to decomposition of the heteroaryl lithium under the salt metathesis conditions. To avoid this problem, the metathesis was conducted with EtZnCl, which enabled the salt metathesis to proceed at low temperatures. The resulting EtZn(Ar(Hetero)) intermediates (Ar(Hetero) = 2- and 3-thiophenyl, 2-benzothiophenyl, 3-furyl, and 5-indolyl) were successfully added to aldehydes and heteroaryl aldehydes with enantioselectivities between 81-99%. These are the first examples of catalytic and highly enantioselective syntheses of diheteroarylmethanols. In a similar fashion, ferrocenyl bromide was used to generate FcZnEt and the ferrocenyl group added to benzaldehyde and heteroaromatic aldehydes to form ferrocene-based ligand precursors in 86-95% yield with 96-98% ee. It was also found that the arylation and heteroarylation of enals could be followed by diastereoselective epoxidations to provide epoxy alcohols with high enantio- and diastereoselectivities in a one-pot procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653691      PMCID: PMC2755092          DOI: 10.1021/ja9046747

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  70 in total

1.  Planar-Chiral Heterocycles as Ligands in Metal-Catalyzed Processes: Enantioselective Addition of Organozinc Reagents to Aldehydes.

Authors:  Peter I. Dosa; J. Craig Ruble; Gregory C. Fu
Journal:  J Org Chem       Date:  1997-02-07       Impact factor: 4.354

2.  Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.

Authors:  K L Yu; P Spinazze; J Ostrowski; S J Currier; E J Pack; L Hammer; T Roalsvig; J A Honeyman; D R Tortolani; P R Reczek; M M Mansuri; J E Starrett
Journal:  J Med Chem       Date:  1996-06-07       Impact factor: 7.446

3.  Catalytic enantioselective arylation of aldehydes: boronic acids as a suitable source of transferable aryl groups.

Authors:  Antonio L Braga; Diogo S Lüdtke; Fabrício Vargas; Marcio W Paixão
Journal:  Chem Commun (Camb)       Date:  2005-04-01       Impact factor: 6.222

4.  Recent applications of chiral ferrocene ligands in asymmetric catalysis.

Authors:  Ramón Gómez Arrayás; Javier Adrio; Juan Carlos Carretero
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

5.  Triarylborane ammonia complexes as ideal precursors for arylzinc reagents in asymmetric catalysis.

Authors:  Stefan Dahmen; Matthias Lormann
Journal:  Org Lett       Date:  2005-10-13       Impact factor: 6.005

6.  A green chemistry approach to a more efficient asymmetric catalyst: solvent-free and highly concentrated alkyl additions to ketones.

Authors:  Sang-Jin Jeon; Hongmei Li; Patrick J Walsh
Journal:  J Am Chem Soc       Date:  2005-11-30       Impact factor: 15.419

7.  The antihistaminic and anticholinergic activities of optically active diphenhydramine derivatives. The concept of complementarity.

Authors:  R F Rekker; H Timmerman; A F Harms; W T Nauta
Journal:  Arzneimittelforschung       Date:  1971-05

8.  Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.

Authors:  Mohammed Reza Saberi; Tai Ky Vinh; Sook Wah Yee; B J Nathan Griffiths; Peter J Evans; Claire Simons
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

Review 9.  Nonsteroidal aromatase inhibitors: recent advances.

Authors:  Maurizio Recanatini; Andrea Cavalli; Piero Valenti
Journal:  Med Res Rev       Date:  2002-05       Impact factor: 12.944

10.  Acceleration of arylzinc formation and its enantioselective addition to aldehydes by microwave irradiation and aziridine-2-methanol catalysts.

Authors:  Antonio L Braga; Marcio W Paixão; Bernhard Westermann; Paulo H Schneider; Ludger A Wessjohann
Journal:  J Org Chem       Date:  2008-03-04       Impact factor: 4.354

View more
  3 in total

1.  One-pot catalytic enantio- and diastereoselective syntheses of anti-, syn-cis-disubstituted, and syn-vinyl cyclopropyl alcohols.

Authors:  Hun Young Kim; Luca Salvi; Patrick J Carroll; Patrick J Walsh
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

2.  Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.

Authors:  Tyler D Baguley; Hai-Chao Xu; Manavi Chatterjee; Angus C Nairn; Paul J Lombroso; Jonathan A Ellman
Journal:  J Med Chem       Date:  2013-10-01       Impact factor: 7.446

3.  Catalytic enantioselective aryl transfer to aldehydes using chiral 2,2'-bispyrrolidine-based salan ligands.

Authors:  Xuefeng Jia; Aijun Lin; Zhijie Mao; Chengjian Zhu; Yixiang Cheng
Journal:  Molecules       Date:  2011-04-06       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.